Trial intelligence / Profile preview

REducing blood pressure Variability in Essential hypertension with RAmipril vErsus Nifedipine GITS Trial

2014-003459-76Phase 4Completed

Sponsor
Istituto Auxologico Italiano
Start
Oct 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in essential hypertension comparing Nifedipine GITS arm with Ramipril arm (2 arms). Primary endpoint: Variability (standard deviation) of home systolic blood pressure. Started Oct 2014; status: completed.

02

Drugs

nifedipineramipril
03

Conditions

essential hypertension

Beyond the preview

Go deeper on 2014-003459-76.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-003459-76.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call